Biogen Has Many `Exciting' Drugs in Pipeline: CEO

Jan. 14 (Bloomberg) -- George Scangos, chief executive officer Biogen Idec Inc., talks about the company's multiple sclerosis drugs, pipeline and outlook. Scangos speaks with Erik Schatzker and Stephanie Ruhle on Bloomberg Television's "Market Makers." (Source: Bloomberg)
Greek Government Has Gotten Themselves in a Corner: Foley
54:22 - Rabobank Senior FX Strategist Jane Foley discusses the Greek referendum and Greek Finance Minister Yanis Varoufakis’ blog post about the stalemate. She speaks to Bloomberg’s Anna Edwards on “Countdown.” (Source: Bloomberg)
  • When Will the Fed Raise Rates?
  • A Deal With Iran Is More Likely Than Not: Soltvedt
  • Role of ECB in the Crisis Is Very Crucial: Foley